Pipeline

Product Candidate
Phase
Milestones
Prophylactic Vaccines
Norovirus
Phase 1 Noro GI.1/GII.4
  • Bivalent Study Complete
Influenza
Phase 1
  • License and/or partner
Respiratory Syncytial Virus (RSV)
Preclinical
  • License and/or partner
Covid-19
Phase 2
  • Complete Phase 2
Therapeutic Vaccines
Human papillomavirus (HPV)
Preclinical vaccine (dysplasia/cancer)
  • Pre-IND

See our Current Pipeline

We are currently focusing on the development of our coronavirus vaccine. We are actively looking for a partner for our influenza vaccine program. All Vaxart vaccine trials are conducted by U.S.-based contract research organizations under good clinical practices (GCP). Vaxart vaccines are manufactured under good manufacturing practices (GMP) in the U.S. The Vaxart vaccine is administered as a convenient enteric-coated tablet.

Reference: Vaxart data on file.